IRX3 and obesity due to melanocortin 4 receptor deficiency: We also found significantly lower expression of IRX3 in the subcutaneous fat of obese subjects, which was consistent with two previous studies (Dankel et al., 2010; Landgraf et al., 2016), further supporting the involvement of IRX3 in human obesity.